Making Informed Choices for the Nutritional Management of Infants with CMA

This symposium focused on the latest international guidelines for management of cow’s milk allergy (CMA) and highlighted the clinical relevance of emerging data on the physico-chemical properties of extensively hydrolyzed formula (eHF). The experts presented the nutritional management of cow’s milk protein allergy (CMPA) based on ESPGHAN 2024 guidelines, emphasizing the importance of meeting the infant’s nutritional requirements while supporting immune development and healthy growth. The discussion also examined key factors influencing the effectiveness and tolerability of protein hydrolysates in infants with CMA, alongside the latest research on eHF as the first-line treatment when breastfeeding is not possible.